Please login to the form below
Zarzio
This page shows the latest Zarzio news and features for those working in and with pharma, biotech and healthcare.
Clock ticking on biosimilar Enbrel in US
In markets outsider the US - where it is known as Zarzio and has been available since 2006 - Sandoz' drug has captured around a 30% share of the Neupogen market.
Latest news
-
Novartis launches first biosimilar Zarxio in the US
therapies.”. Biosimilars have been available in Europe since 2006 and Zarxio is already available in more than 40 countries under the brand name Zarzio, where it has captured around 30% of
-
Apotex latest to file Neupogen biosimilar in the US
the brand name Zarzio.
-
FDA close to first biosimilar approval
US under the brand name Zarzio.
-
Biosimilars could make EU big cost savings after slow start
In the case of Amgen's once-daily white blood cell stimulator Neupogen (filgrastim), however, the drug has now been overtaken by its biosimilar rivals - led by Sandoz' Zarzio - and the
-
FDA 'must publish biosimilar naming guide soon'
as Zarzio - in Europe in 2009. ... According to the company Zarzio is the leading G-CSF in Europe with a 30 per cent market share.
More from news
Approximately 2 fully matching, plus 8 partially matching documents found.
Latest Intelligence
-
Customer experience rules the digital age
Establishing an effective customer journey
-
Embracing digital disruption in pharma
LEO Innovation Lab and some of its successes to date
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Swordfish Advertising
Zarzio. Omnitrope. Adoport. Adoport International. Mezolar Matrix. Pain portfolio. Mometasone. Shire Pharmaceuticals.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
-
Healthcare PR Senior Account Manager
-
Salary TBC
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
-
Sudler London - Account Director
-
Competitive
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
-
Systematic Review Lead- London
-
Negotiable
-
Associate Scientific Director
-
Salary TBC
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
-
Account Manager
-
Negotiable
- Senior Writer, Healthcare Advertising, London
-
Excellent package
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
Subscribe to our email news alerts
PMHub
Research Partnership
We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the...
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
